Chancery Approves Amneal Settlement, $1.88M Atty Fee
A settlement between Amneal Pharmaceuticals Inc., its shareholders, and several Amneal affiliates over an alleged unfair deal for a bundle of early-stage drug candidates got court approval in Delaware Tuesday, with...To view the full article, register now.
Already a subscriber? Click here to view full article